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Abstract 
Background: Etomidate is suitable for induction of anesthesia, especially in 
elderly patients and patients who have a cardiovascular compromise. Vitamin 
C has been introduced as a treatment option to decrease Etomidate-induced 
adrenal insufficiency but its actual effect is still controversial. The objective is 
to determine the effect of vitamin C on the reduction of serum cortisol after 
Etomidate induction of anesthesia.  
Materials and Methods: In a randomized clinical trial, 40 patients of the 
American Society of Anesthesiologists (ASA) class I and II, aged between 25 
to 70 years old, candidates for elective laparotomy were selected. One hour 
before induction of surgery, 1 gram of intravenous vitamin C was 
administered to the patients in the vitamin C group. Two blood samples were 
obtained 5 minutes before induction and then another sample 4 hours after 
induction with Etomidate after surgery. All samples were measured for 
serum-free cortisol, ACTH, and C-reactive protein (CRP).  
Results: There were no significant differences between the duration of 
surgery, pre-operative and post-operative blood pressure, and heart rate in 
the two groups (p>0.05). Serum cortisol was significantly declined in the 
control group from 16.2±6.3 μg/dl in pre-operative to 8.5±4.2 in post-
operative (p=0.0005), but not in the vitamin C group from 17.5±5.6 in pre-
operative to 16.8±6.4 in post-operative (p=0.75). ACTH levels increased 
non-significantly from pre-operative to post-operative period in both 
vitamin C (pre-operative: 52.1±15 vs. post-operative: 56.4±18 pg/ml) 
(p=0.48) and in control group (pre-operative: 50.5±16 vs. post-operative: 
56.2±20).  
Conclusion: Etomidate could significantly decrease post-operative serum-
free cortisol and induce adrenocortical suppression and CRP increase. This 
effect could be reversed by using vitamin C premedication to maintain serum 
cortisol at the pre-operative level. 
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Introduction 
Etomidate is an imidazole derivative used primarily 
for induction of anesthesia, especially in elderly 
patients and patients who have a cardiovascular 
compromise. These beneficial properties led to 
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widespread use of Etomidate for induction, 
maintenance of anesthesia, and prolonged sedation in 
critically ill patients (1). The major advantage of 
Etomidate is its minimal effect on the cardiovascular 
and respiratory systems. The hemodynamic stability 
seen with Etomidate may be due partly to its unique 
lack of effect on the sympathetic nervous system and 
baroreceptor function (2). 
Anesthesiologists' enthusiasm for Etomidate 
was tempered, however, by reports that the drug can 
cause temporary inhibition of steroid synthesis after 
single doses and infusions (3). This effect, combined 
with other minor disadvantages such as myoclonus 
led to several editorials questioning the role of 
Etomidate in modern anesthetic practice (4). Because 
minor adrenocortical suppressive effects were shown 
to follow even single bolus doses, concerns about the 
use of Etomidate for anesthetic induction arose (5, 6). 
Etomidate administration was associated with a trend 
toward a relative increase in mortality (7). 
The specific endocrine effects manifested by 
Etomidate are a dose-dependent reversible inhibition 
of the 11β-hydroxylase which converts 11-
deoxycortisol to cortisol and a relatively minor effect 
on 17α-hydroxylase (8). This activity results in to 
increase in ACTH.  
Temporary adrenocortical suppression, as 
measured by a reduced response to ACTH 
stimulation, was documented for 6 hours post-
operative and returned to normal by 20 hours post-
operative. Boidin et al. introduce vitamin C as a 
treatment option to decrease Etomidate induced 
adrenal insufficiency. However, vitamin C's effect on 
the prevention of adrenal suppression induced by 
etomidate is still controversial. The main objective of 
this study was to determine the effect of vitamin C on 
the reduction of serum cortisol after Etomidate 
induction of anesthesia. 
 
Methods 
The study was reviewed and approved by the 
University Review Board and hospital ethics 
committee and been performed following the ethical 
standards laid down in an appropriate version of the 
2000 Declaration of Helsinki. Also, the study was 
registered in IRCT.ir with this ID: IRCT 
IRCT201511252804N10. Trial information was given 
comprehensively both orally and in written form to 
the patients. All patients gave their written informed 
consents before their inclusion in the study according 
to University Hospital Ethics Board Committee.  
Patient selection: in a randomized clinical trial, 
46 patients of the American Society of 
Anesthesiologists (ASA) class I and II, aged between 
25 to 70 years old, candidates for elective laparotomy 
were selected. Patients were excluded if they had a 
severely disabling illness, Addison or Cushing 
disease, septic shock or severe sepsis, trauma, history 
of corticosteroid intake at a dose that could suppress 
cortico-pituitary-adrenal, and duration of surgery 
longer than 4 hours or extreme changes in 
hemodynamics during surgery. A pre-operative visit 
was performed before the surgery. Six patients were 
excluded from the study.  
Forty-six patients enrolled and 6 were 
excluded; 40 patients were randomly (accidental 
numbers) assigned to one of the controls or vitamin C 
groups (Figure1). Randomization was performed 
before the surgery. The anesthesiologist administering 
drugs were blind to the group of patients and the 
syringes contain (concealment allocation).  
Vitamin C administration: patients were 
randomly assigned to group vitamin C or Control. All 
patients entered the operating room (OR) at 8 a.m. 
Then, 1 hour before induction of surgery, 1 gram of 
intravenous vitamin C was administered to the 
patients in the vitamin C group. The Control group 
received the same volume of normal saline in the 
same color syringes.  
Monitoring and Anesthesia: all patients were 
monitored for standard monitoring including ECG, 
Oxygen saturation pulse oximetry, non-invasive blood 
monitoring, and end-tidal CO2 monitoring.  
Patients were pre-oxygenated with 5 lit/min 
100% O2 for 3 to 5 min. Anesthesia was induced by 
the same method in all patients. For premedication, 
fentanyl 5 μg/kg and midazolam 0.02 mg/kg were 
administered. Three minutes later the anesthesia was 
induced by Etomidate 0.3 mg/kg and Lidocaine 1.5 
mg/kg and cisatracurium 0.2 mg/kg. Intubation was 
performed under smooth direct laryngoscopy after 60-
90 seconds when TOF=0. Endotracheal tube size was 
selected after laryngoscopy under direct visualization. 
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Anesthesia was maintained with 1 minimum alveolar 
anesthetic concentration (MAC) isoflurane and 50% 
nitrous oxide/50% oxygen. Extubation was performed 
using the same method in both groups. After surgery, 
when TOF>0.7 and the patient was fully awaked, 
neuromuscular block was reversed (Neostigmin 0.05 
mg/kg+Atropin=0.02 mg/kg) and extubated. In 
recovery, patients only had O2 5 lit/min via face 
mask.  
Fluid therapy was performed using the 
standard method. Patients were covered with 3 layers 
of surgical drapes. The ambient temperature was 
measured by a wall thermometer and the room 
temperature was maintained at 23C.  
Blood Sampling: two blood samples were 
obtained from patients including one sample 5 
minutes before induction with etomidate and then 
another sample 4 hours after induction with 
Etomidate after surgery in recovery or ward. All 
samples were measured for serum-free cortisol, 
ACTH, and C reactive protein (CRP). Blood pressure, 
heart rate, and oxygen saturation were recorded 
before surgery and every 2 hours after anesthesia.  
Statistical Analysis: statistical calculations 
were conducted using SPSS 18 (Chicago, IL, USA). 
The parametric variables were presented as mean±SD 
and were analyzed by student t-test; nonparametric 
variables were analyzed by Chi-Square or Mann-
Whitney U-test. P<0.05 was considered statistically 
significant. The sample size was estimated using 
sample size calculator software with 95% confidence 
interval, p=0.05, and power of 80%, and the 
difference between two groups of 70% in primary 
outcome based on the pilot study. 
 
Results 
In this randomized clinical trial, 46 patients were 
enrolled in the study, of which 6 were excluded and 
40 of them randomly assigned to one of the groups. 
Twenty of them received vitamin C and 20 patients 
received normal saline. Age, sex, and body mass 
index (BMI) were not significantly different between 
the two groups of study (p>0.05) (Table1).  
Hemodynamics: there were no significant 
differences in the duration of surgery between the two 
groups (p>0.05). Pre-operative and post-operative 
blood pressure and heart rate were not significantly 
different in two groups of study (p>0.05; Table2).  
Serum Cortisol, ACTH and CRP: serum 
cortisol was significantly declined in control group 
from 16.2±6.3 in pre-operative sample to 8.5±4.2 in 
post-operative (p=0.0005). However, cortisol did not 
decrease significantly in vitamin C group from 
17.5±5.6 in preoperative sample to 16.8±6.4 in 
postoperative sample (p=0.75) (Figure2).  
ACTH serum levels increased non-
significantly from pre-operative to post-operative 
period in both vitamin C group (pre-operative: 
52.1±15 vs. post-operative: 56.4±18) (p=0.48) and in 
 
 
Table 1: Comparison of demographic 
characteristics of patients in two groups. 
 Vit C  Control  p-
value  
Age (years)  52.4±
15.6  
54.7±14.6  0.56*  
Sex (Male/Female)  10/5  12/3  0.62¥  
BMI  24.6±
4.3  
23.7±4.56  0.39*  







































BMI: Body mass index; ASA: American Society of 
Anesthesiology  
*t-test; ¥ Chi-Square 
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control group (pre-operative: 50.5±16 vs. post-
operative:56.2±20; p=0.39) (Figure 2).  
Serum CRP was significantly increased in the 
control group from pre-operative (0.97±0.8) to post-
operative (2.32±1.25), the p-value was p=0.0015, 
while it did not significantly increase in the vitamin C 
group from pre-operative (0.92±0.75) to post-
operative  (1.1±0.80) with p-value p=0.52 (Figure 3). 
 
Discussion 
Our study showed that Etomidate induction reduces 
serum cortisol in the control group but not when 
vitamin C premedication is administered. On the other 
hand, Etomidate did not decrease ACTH secretion. 
However, ACTH secretion was not sufficient to 
increase cortisol due to inhibition of 11-β-hydroxylase 
(11). 
In our study, cortisol level significantly 
decreased in the control group after Etomidate 
induction but in the vitamin C group, free serum 
cortisol did not significantly decrease. Although this 
is not in contrast to other studies when evaluating 
Etomidate induction doses; none reported adverse 
outcomes secondary to short-term adrenocortical 
suppression. In other studies documenting Etomidate 
induced adrenocortical suppression without associated 
clinical sequela; a conclusion of safety was not 
forthcoming. The reason was that these studies did 
not address high-stress procedures, in which the 
benefit of a high cortisol level in response to major 
 
Table 2: Comparison of duration of surgery and 
hemodynamic of patients in two groups. 
 Vit C  Control  p 
value*  
Duration of 
Surgery (hours)  
2.7±1.34  2.89±1.27  0.54  
Mean arterial 































Fig. 1. Consort flowchart of the study. 
 
Fig. 2. Comparison of serum CRP between pre and postoperation in Vitamin C and control groups. 
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stress could be desirable, and blockade of the 
response to ACTH by Etomidate could be 
detrimental. Etomidate could induce a potential risk 
for patients with high-risk surgeries and frail patients 
with trauma, cardiac surgery (12), or septic shock (13) 
and should be avoided (14). Administration of 
Etomidate for rapid sequence intubation is associated 
with higher rates of adrenal insufficiency and 
mortality in patients with sepsis (15). 
In our study, mean cortisol levels in the 
vitamin C group did not decrease significantly 
postoperatively. The blockade of 11β-hydroxylase 
seems to be related to the free imidazole radical of 
Etomidate-binding cytochrome P-450 (16). This 
results in inhibition of ascorbic acid re-synthesis, 
which is required for steroid production in humans. 
Blockade of the cytochrome P-450 dependent enzyme 
11β-hydroxylase also results in decreased 
mineralocorticoid production particularly in critically 
ill patients (17). Therefore, vitamin C 
supplementation could restore cortisol levels to 
normal after the use of Etomidate. However few 
research contradicts this effect that vitamin C given 
before anesthesia achieved by Etomidate is not 
sufficient for the prevention of surgical stress 
response (18). 
Our experiment suggests that the issue of 
adrenocortical suppression after perioperative 
induction doses of Etomidate will be reversed by 
vitamin C after laparotomies. Duthie and his 
colleagues showed that in otherwise healthy patients 
undergoing minor peripheral surgery, plasma cortisol 
levels were slightly depressed from the pre-induction 
levels for 1 hour postoperatively and the nadir of 
mean cortisol levels did not fall out of the normal 
range (19). However, high-stress surgery can 
overcome the temporary adrenocortical suppression 
caused by Etomidate to induce a clinically significant 
level of cortisol deficiency and adrenocortical 
suppression. Vitamin C premedication could reverse 
Etomidate induced adrenocortical suppression 
phenomenon. Other studies showed no evidence of a 
clinically relevant attenuating effect of ascorbic acid 
or xylitol on Etomidate-induced adrenocortical 
suppression (20, 21). 
 
Conclusion 
Etomidate could significantly decrease post-operative 
serum-free cortisol and induce adrenocortical 
suppression and CRP increase. This effect could be 
reversed by using vitamin C premedication to 
maintain serum cortisol at the pre-operative level. 
This would be of paramount importance in fragile 
patients and high-stress surgeries. 
 
Acknowledgment 
The authors would like to acknowledge the kind 
efforts of the operating room physicians and nurses of 
Modarres Hospital, Tehran, Iran for their cooperation 
and kind help.  
 
Conflicts of Interest  




1.  Gooding JM, Weng JT, Smith RA, Berninger GT, Kirby RR. 
Cardiovascular and pulmonary responses following etomidate 
induction of anesthesia in patients with demonstrated cardiac 
disease. Anesth Analg. 1979;58(1):40-1. 
2. Ebert TJ, Muzi M, Berens R, Goff D, Kampine JP. Sympathetic 
responses to induction of anesthesia in humans with propofol or 
etomidate. Anesthesiology. 1992;76(5):725-33. 
3. Ledingham IM, Watt I. Influence of sedation on mortality in 
critically ill multiple trauma patients. Lancet. 1983;1(8336):1270. 
4. Owen H, Spence AA. Etomidate. Br J Anaesth. 1984;56(6):555-7. 
5. Allolio B, Dörr H, Stuttmann R, Knorr D, Engelhardt D, 
 
Fig. 3.  Comparison of serum CRP between pre and 
post-operation in Vitamin C and control groups. 
Vitamin C and Serum Cortisol Level after Etomidate Anesthesia                                                               Nooraei et al. 
Vol 1, No 1, Winter 2016 
33 
Winkelmann W. Effect of a single bolus of etomidate upon eight 
major corticosteroid hormones and plasma ACTH. Clin Endocrinol 
(Oxf). 1985;22(3):281-6. 
6. Longnecker DE. Stress free: to be or not to be? Anesthesiology. 
1984;61(6):643-4. 
7. Sunshine JE, Deem S, Weiss NS, Yanez ND, Daniel S, Keech K, 
et al. Etomidate, adrenal function, and mortality in critically ill 
patients. Respir Care. 2013;58(4):639-46. 
8. Lamberts SW, Bons EG, Bruining HA, de Jong FH. Differential 
effects of the imidazole derivatives etomidate, ketoconazole and 
miconazole and of metyrapone on the secretion of cortisol and its 
precursors by human adrenocortical cells. J Pharmacol Exp Ther. 
1987;240(1):259-64. 
9. Vinclair M, Broux C, Faure P, Brun J, Genty C, Jacquot C, et al. 
Duration of adrenal inhibition following a single dose of etomidate 
in critically ill patients. Intensive Care Med. 2008;34(4):714-9. 
10. Boidin MP. Steroid response to ACTH and to ascorbinic acid 
during infusion of etomidate for general surgery. Acta Anaesthesiol 
Belg. 1985;36(1):15-22. 
11. Crozier TA, Beck D, Schlaeger M, Wuttke W, Kettler D. 
Endocrinological changes following etomidate, midazolam, or 
methohexital for minor surgery. Anesthesiology. 1987;66(5):628-35. 
12. Wagner CE, Bick JS, Johnson D, Ahmad R, Han X, Ehrenfeld 
JM, et al. Etomidate use and postoperative outcomes among cardiac 
surgery patients. Anesthesiology. 2014;120(3):579-89. 
13. de la Grandville B, Arroyo D, Walder B. Etomidate for critically 
ill patients. Con: do you really want to weaken the frail? Eur J 
Anaesthesiol. 2012;29(11):511-4. 
14. van den Heuvel I, Wurmb TE, Böttiger BW, Bernhard M. Pros 
and cons of etomidate--more discussion than evidence? Curr Opin 
Anaesthesiol. 2013;26(4):404-8. 
15. Chan CM, Mitchell AL, Shorr AF. Etomidate is associated with 
mortality and adrenal insufficiency in sepsis: a meta-analysis*. Crit 
Care Med. 2012;40(11):2945-53.  
16. Boidin MP, Erdmann WE, Faithfull NS. The role of ascorbic 
acid in etomidate toxicity. Eur J Anaesthesiol. 1986;3(5):417-22. 
17. Malerba G, Romano-Girard F, Cravoisy A, Dousset B, Nace L, 
Lévy B, et al. Risk factors of relative adrenocortical deficiency in 
intensive care patients needing mechanical ventilation. Intensive 
Care Med. 2005;31(3):388-92. 
18. Pirbudak L, Balat O, Cekmen M, Ugur MG, Aygün S, Oner U. 
Effect of ascorbic acid on surgical stress response in gynecologic 
surgery. Int J Clin Pract. 2004;58(10):928-31. 
19. Duthie DJ, Fraser R, Nimmo WS. Effect of induction of 
anaesthesia with etomidate on corticosteroid synthesis in man. Br J 
Anaesth. 1985;57(2):156-9. 
20. Schraag S, Pawlik M, Mohl U, Böhm BO, Georgieff M. The 
role of ascorbic acid and xylitol in etomidate-induced adrenocortical 
suppression in humans. Eur J Anaesthesiol. 1996;13(4):346-51. 
21. Dabbagh A, Sa'adat N, Heidari Z. Etomidate infusion in the 
critical care setting for suppressing the acute phase of Cushing's 
syndrome. Anesth Analg. 2009;108(1):238-9.
 
